, or “divalproex sodium” was marketed for the treatment and control of various seizure disorders. The U.S. Food and Drug Administration (FDA) has specifically approved the product for the treatment of manic episodes for those patients who suffer from bipolar disorders. After the initial approval, physicians also began prescribing the drug for other disorders such as migraine headaches and in rare cases, major depression. The updated webpage explores the severe Depakote side effects and offers insight to those who are exploring the possibility of filing their own Depakote lawsuit.
The updates on the webpage for Depakote include studies that link Depakote to a high rate of birth defects as opposed to other competing antiepileptic drugs. One particular study shows that a newborn is 12 times more likely to develop spina bifida (a birth defect in which the fetus’ backbone and spinal canal do not close before birth) in cases where the mother has taken Depakote, in comparison to children born to women who have not taken it. That study, which was conducted at the University of Groningen in the Netherlands, also reports that the child is five times more likely to develop a cleft lip or cleft palate birth defect and also, twice as likely of developing an atrial septal, or congenital heart defect. d’Oliveira & Associates’ updated webpage also details the numerous other Depakote side effects which include pulmonary valve stenosis, neural tube defects, craniosynososis, and hypospadias, and fetal death.
In addition to this, the FDA has also issued stern warnings about Depakote in saying that the drug is related to increased risks of neural tube defects, and other birth defects including craniofacial defects and cardiovascular malformations. The FDA has urged potential childbearing women to use other drugs such as Valproate, instead of Depakote unless essential for their medical condition. Moreover, the renowned publications Neurology and The New England Journal of Medicine have each published articles linking Depakote use in women to lower IQs to the children they gave birth to while on the drug. Most telling about Depakote is that the Neurodevelopmental Effects of Antiepileptic Drugs study group has concluded that Depakote be the “bottom of the list” of recommended antiepileptic drugs.
d’Oliveira & Associates deals with cases involving injuries or side effects caused by dangerous drugs, including Depakote. Its updated webpage will provide useful information to individuals who have used Depakote, gave birth to children with certain birth defects, and are in doubt as to whether they have a claim or not. Visit our webpage on Depakote, and find out if your child exhibits any of the symptoms or birth defects in determining if you need a R.I. Depakote lawyer.
If you, your children, or someone you know has suffered any of these severe side effects, you may be entitled to compensation. The attorneys at d’Oliveira & Associates are working with the leading dangerous drug lawyers in the country and Rhode Island Depakote attorneys and want you to know that you deserve the right legal representation for your Depakote lawsuit. Please contact the law offices of d’Oliveira & Associates at 1-800-992-6867 or fill out a contact form for a free legal consultation.